Risk of cancer in patients with psoriasis on biological therapies: a systematic review

ConclusionsThere were important limitations to the studies identified including choice of comparator arms, inadequate adjustment for confounding factors and failure to account for latency periods of cancer. There remains a need for ongoing pharmacovigilance in relation to cancer risk and biological therapy; the NMSC signal requires further investigation to determine the risk specifically attributable to biological therapy using prospectively collected data with adjustment for known NMSC risk factors.
Source: British Journal of Dermatology - Category: Dermatology Authors: Tags: Systematic Review Source Type: research